Carole Mitnick

13PUBLICATIONS
56CO-AUTHORS
Behavioural epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)Disease surveillanceMajor global burdens of diseaseHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jan 29, 2025
Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis.

Lorenzo Guglielmetti, Uzma Khan, Gustavo E Velásquez

|Dec 10, 2024
The Frequency and Incidence of QT Prolongation With Extended Use of Bedaquiline or Delamanid in a Large, Multi-Country Multidrug-Resistant/Rifampicin-Resistant Tuberculosis Cohort.

Uzma Khan, Michael Rich, Molly F Franke

|Sep 10, 2023
"Post tuberculosis": the urgent need for inclusion of lung health outcomes in tuberculosis treatment trials.

Anthony Byrne, Brian Allwood, Ingrid Schoeman

|Mar 23, 2023
Ascertainment Bias in TB Treatment Trials: Can Systematic Assessment of Objective Endpoints Solve It?

Carole D Mitnick, Andrew J Nunn

|Jan 10, 2023
The 1/4/6x24 campaign to cure tuberculosis quickly.

Lindsay McKenna, Mike Frick, Ketholelie Angami

Pageof 3